Vitamin D Testing: What 25(OH)D Actually Tells You

The Most Misunderstood Test in Primary Care

Most people get a 1,25-dihydroxyvitamin D test when they should get a 25-hydroxyvitamin D test. And most people who get tested do not need testing at all.

That is not a knock on patients — it is a reflection of genuine confusion in clinical guidelines, a reference range system that varies wildly between labs, and a supplement industry that has turned a simple blood test into a multi-billion-dollar marketing machine.

This guide is about what the test actually measures, which version to order, who actually benefits, and what the numbers mean — without the hype.

What Vitamin D Actually Is

Vitamin D is not a vitamin. It is a pro-hormone — a precursor molecule your body converts into a hormone that regulates calcium absorption, immune function, and bone health across nearly every tissue.

Your body makes it in two ways:

Endogenous synthesis: UV-B radiation from sunlight converts 7-dehydrocholesterol in your skin to previtamin D₃, which thermally converts to vitamin D₃ (cholecalciferol). This is how most people get most of their vitamin D — assuming adequate sun exposure, which is not guaranteed for most people living at higher latitudes or working indoors.

Dietary intake: Vitamin D₂ (ergocalciferol) from fungi and fortified foods, or D₃ from animal sources and supplements, are absorbed in the gut and enter the circulation.

Both D₂ and D₃ are transported to the liver, where they undergo 25-hydroxylation — the first of two activation steps.

The activation chain:

1. Liver: Vitamin D (D₂ or D₃) → 25-hydroxyvitamin D [25(OH)D]
2. Kidney (and other tissues): 25(OH)D → 1,25-dihydroxyvitamin D [1,25(OH)₂D] — calcitriol

Calcitriol is the most biologically active form. It binds the vitamin D receptor (VDR) in intestinal cells, stimulating calcium absorption. But it is tightly regulated — and that regulation is the key to understanding why the two tests are so different.

The Two Tests: 25(OH)D vs. 1,25(OH)₂D

25-Hydroxyvitamin D [25(OH)D] — Order This

This is the gold standard for assessing vitamin D status. It has a half-life of 2–3 weeks and reflects total body stores from both synthesis and dietary intake.

Because it accumulates in the blood at measurable concentrations (ng/mL range), it is the most reliable indicator of whether you have enough vitamin D for basic physiological needs.

What it tells you: Whether your vitamin D supply is adequate. Deficiency → impaired calcium absorption → bone demineralization, muscle weakness, secondary hyperparathyroidism.

Key clinical point: When you are deficient, your parathyroid gland (PTH) senses low calcium and ramps up PTH production, which stimulates the kidneys to convert more 25(OH)D to 1,25(OH)₂D. This means 1,25(OH)₂D can be normal or even elevated even when 25(OH)D is dangerously low — making it useless as a status test.

1,25-Dihydroxyvitamin D [1,25(OH)₂D] — Rarely Ordered

This is the active hormone. It has a half-life of only 4–6 hours and circulates at concentrations ~1,000x lower than 25(OH)D (pg/mL range).

When it is actually useful:

• Chronic kidney disease (CKD): The kidneys cannot convert 25(OH)D to 1,25(OH)₂D efficiently. Patients on dialysis may need active vitamin D (calcitriol) directly rather than supplements.
• Hypercalcemia workup: Elevated 1,25(OH)₂D in the setting of high calcium suggests granulomatous disease (sarcoidosis, tuberculosis, some lymphomas) where macrophages produce 1,25(OH)₂D autonomously.
• Vitamin D-dependent rickets (types I and II): Rare genetic disorders of the activation pathway.
• Monitoring calcitriol therapy: Patients already on active vitamin D medications.

When it is the wrong test: If your goal is to assess whether you have enough vitamin D in your body (which is 99% of clinical scenarios), 1,25(OH)₂D tells you almost nothing useful.

Clinical takeaway: When your doctor says "let us check your vitamin D," confirm they ordered 25-hydroxyvitamin D — and specifically, a test that measures both 25(OH)D₂ and 25(OH)D₃ (total 25[OH]D). Some immunoassays significantly underdetect D₂.

The Reference Range Debate

Here is where it gets genuinely contentious.

The Three Major Positions

Endocrine Society (≥30 ng/mL)

The 2011 guideline (updated in 2024) defines:

• ≥30 ng/mL: Sufficient
• 20–29 ng/mL: Insufficient
• <20 ng/mL: Deficient

Rationale: PTH plateaus at ~30 ng/mL, meaning calcium metabolism is optimized at that threshold. Below 30, PTH starts climbing as the body tries to maintain calcium homeostasis.

Institute of Medicine / National Academy of Medicine (≥20 ng/mL)

• ≥20 ng/mL: Adequate for ~97.5% of the population
• 12–19 ng/mL: May be adequate but some individuals have insufficient intake

Rationale: The IOM set the bar based on bone health outcomes (rickets, osteomalacia, bone density) — and found the evidence for benefits above 20 ng/mL to be insufficient for a population-level RDA. They set the Estimated Average Requirement (EAR) at 16 ng/mL and RDA at 20 ng/mL.

Functional / integrative medicine (>50–60 ng/mL)

Some practitioners aim for 50–80 ng/mL, citing observational data linking higher levels to reduced rates of autoimmune disease, certain cancers, and cardiovascular outcomes.

The honest problem: The clinical trial evidence for supplementation achieving non-skeletal benefits is weak. The VITAL trial (see below) found null results for cancer and cardiovascular disease prevention at 2,000 IU/day over 5+ years.

The USPSTF Weighs In

The 2024 USPSTF recommendation concluded that the current evidence is insufficient to recommend routine vitamin D screening in asymptomatic adults. They specifically note:

• Most adults in the US have levels above 20 ng/mL
• The evidence that treating insufficiency in asymptomatic people improves outcomes beyond bone health is limited
• Testing should focus on people with symptoms, malabsorption, or known risk factors

The practical synthesis: For otherwise healthy adults with no risk factors, the IOM threshold (>20 ng/mL) is a reasonable floor. If you are symptomatic, have malabsorption conditions, or are being worked up for bone disease, aiming for >30 ng/mL (Endocrine Society threshold) is defensible. The >50 ng/mL target lacks solid trial evidence.

Who Should Actually Get Tested

Order 25(OH)D for:

• Malabsorption syndromes: Celiac disease, Crohn's disease, bariatric surgery, cystic fibrosis — these conditions impair fat-soluble vitamin absorption, including D.
• Chronic kidney disease (stage 3+): Affects the 1-alpha hydroxylation step. Monitor both 25(OH)D and 1,25(OH)₂D.
• Osteoporosis or osteopenia workup: Along with calcium, PTH, and bone alkaline phosphatase.
• Hyperparathyroidism (primary or secondary): The calcium/PTH/vitamin D axis is central to diagnosis.
• Unexplained bone pain, muscle weakness, or fatigue — after other causes excluded.
• Medications affecting vitamin D metabolism: Glucocorticoids, anticonvulsants (phenytoin, carbamazepine), cholestyramine — these accelerate vitamin D metabolism.
• Adults with dark skin pigmentation: Higher melanin reduces cutaneous vitamin D synthesis. African Americans, for example, have lower average 25(OH)D levels but bioavailable levels may be similar due to lower vitamin D binding protein (DBP) — a nuance many labs do not address.

Do NOT order routinely for:

• Most healthy adults under 75 with no symptoms and no risk factors
• General wellness screening in asymptomatic people (USPSTF agrees)
• People already supplementing — unless you are checking for toxicity above 100 ng/mL

What the Numbers Mean in Practice

Note on lab variation: Different labs use different assays (immunoassay vs. LC-MS/MS), and results can vary meaningfully between platforms. Always note which lab analyzed your sample, and if switching labs, recheck levels rather than comparing historical numbers directly.

The Supplementation Question: What VITAL Actually Showed

The VITAL trial (NCT01169259) was a 2×2 factorial RCT of 25,871 adults (median age 67) randomized to:

• Vitamin D₃ 2,000 IU/day vs. placebo
• Omega-3 1g/day vs. placebo

Median follow-up: 5.3 years

Primary results (published NEJM 2019):

• Invasive cancer: No significant difference (HR 0.96)
• Major cardiovascular events: No significant difference (HR 0.97)

Notable secondary/ancillary findings:

• Advanced (metastatic or fatal) cancer: 17% reduction with vitamin D (HR 0.83, 95% CI: 0.69–0.99) — driven primarily by normal-weight participants
• Autoimmune disease: 22% reduction (HR 0.78) — preliminary, needs replication
• Diabetes risk: Modest reduction in age-adjusted analyses

What VITAL did NOT show:

• No cardiovascular benefit in the overall population
• No general cancer prevention benefit
• No mortality reduction from vitamin D alone

The bottom line on supplementation:

• 1,000–2,000 IU/day is a reasonable maintenance dose for most adults
• The IOM RDA (600–800 IU/day) is adequate for bone health in the majority of the population
• Above 4,000 IU/day exceeds the tolerable upper intake level and should be medically supervised
• Routine high-dose supplementation (10,000+ IU) is not supported by evidence and carries toxicity risk

If you are deficient (25[OH]D <20 ng/mL), a higher loading dose for 8–12 weeks followed by maintenance is the standard approach. If you are sufficient, supplementation offers limited evidence of additional benefit — but is not unreasonable at moderate doses.

Related reading: Understanding Your Lipid Panel covers how to pair vitamin D testing with comprehensive cardiovascular risk assessment, and Thyroid Function Tests Explained addresses the calcium/vitamin D/thyroid axis for people on thyroid replacement therapy.

Frequently Asked Questions

Should I get my vitamin D tested?
Most healthy adults without symptoms, malabsorption conditions, bone disease, or kidney disease do not need routine testing. If you are over 65, have dark skin, get limited sun exposure, or have unexplained fatigue or bone pain — discuss testing with your provider.

What is a normal vitamin D level?
There is no single answer. The IOM says ≥20 ng/mL is adequate; the Endocrine Society says ≥30 ng/mL is sufficient. Most labs report 20–50 ng/mL as the reference range, but "normal" does not mean "optimal" for every person.

How much vitamin D should I take?
For most adults, 600–2,000 IU/day is a reasonable maintenance range. Do not exceed 4,000 IU/day without medical supervision. If you are deficient, your provider may prescribe a higher loading dose for a defined period.

I live in a northern latitude — do I need more testing or supplementation?
Geographic location affects UV-B availability, especially in winter months above ~37° latitude (roughly the latitude of Atlanta and south). People in northern regions often have lower baseline levels. Consider testing if you have other risk factors.

Can I get enough vitamin D from sunlight alone?
Possibly, but it is difficult to quantify and depends on skin exposure area, time of day, season, skin pigmentation, and sunscreen use. Roughly 15–20 minutes of midday sun on face and arms provides ~1,000–2,000 IU of D₃ in fair-skinned individuals — but this is not reliable for everyone year-round.

Does vitamin D help with mood or fatigue?
Low vitamin D is associated with depression and fatigue in observational studies. However, supplementation trials in non-deficient individuals have shown mixed results. If you have mood or fatigue symptoms, testing your level is reasonable — but do not expect supplements to be a magic fix.

Should I take D₂ or D₃?
D₃ (cholecalciferol) is preferred — it is the form your skin makes, raises 25(OH)D levels more efficiently, and has a longer half-life in some studies. D₂ (ergocalciferol) is derived from plants and is equally valid if you are vegan or have a specific clinical reason.

Do I need to fast for a vitamin D test?
No. 25(OH)D is not significantly affected by fasting or time of day. You can take your supplements as usual before the test.